These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 35582848

  • 1. Preliminary evaluation of a small interfering RNA molecular probe targeting murine double minute 2 in breast cancer.
    Wang X, Xu P, Jiao Y, Luan S, Gao Y, Zhao C, Fu P.
    Nucl Med Commun; 2022 Aug 01; 43(8):869-876. PubMed ID: 35582848
    [Abstract] [Full Text] [Related]

  • 2. Molecular imaging of MDM2 messenger RNA with 99mTc-labeled antisense oligonucleotides in experimental human breast cancer xenografts.
    Fu P, Shen B, Zhao C, Tian G.
    J Nucl Med; 2010 Nov 01; 51(11):1805-12. PubMed ID: 20956468
    [Abstract] [Full Text] [Related]

  • 3. Noninvasive evaluation of HABP1 expression with 99mTc-labeled small-interference RNA in ovarian cancer.
    Duan C, Gao Y, Luan S, Guo S, Cao X, Xu P, Fu P, Zhao C.
    Int J Radiat Biol; 2021 Nov 01; 97(11):1569-1577. PubMed ID: 34402389
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
    Li F, Cheng T, Dong Q, Wei R, Zhang Z, Luo D, Ma X, Wang S, Gao Q, Ma D, Zhu X, Xi L.
    Nucl Med Biol; 2015 Mar 01; 42(3):256-62. PubMed ID: 25516099
    [Abstract] [Full Text] [Related]

  • 5. SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe 99mTc-HYNIC-H6F in Breast Cancer Mouse Models.
    Li L, Wu Y, Wang Z, Jia B, Hu Z, Dong C, Wang F.
    J Nucl Med; 2017 May 01; 58(5):821-826. PubMed ID: 28104744
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [99mTc]Tc-HYNIC-RM2: A potential SPECT probe targeting GRPR expression in prostate cancers.
    Vats K, Chakraborty A, Rakshit S, Damle A, Sarma HD, Satpati D.
    Nucl Med Biol; 2023 May 01; 118-119():108331. PubMed ID: 36933456
    [Abstract] [Full Text] [Related]

  • 9. [99mTc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a αvβ3-positive tumor.
    Kaihani S, Sadeghzadeh N, Abediankenari S, Abedi SM.
    Ann Nucl Med; 2022 Nov 01; 36(11):976-985. PubMed ID: 36097232
    [Abstract] [Full Text] [Related]

  • 10. [In-vivo tumor imaging by radiolabeled RNA probe targeting telomerase].
    Wang RF, Kang L, Xu XJ, Yan P, Zhang CL, Liu M.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr 18; 45(2):250-4. PubMed ID: 23591346
    [Abstract] [Full Text] [Related]

  • 11. Imaging CXCR4 Expression with (99m)Tc-Radiolabeled Small-Interference RNA in Experimental Human Breast Cancer Xenografts.
    Fu P, Tian L, Cao X, Li L, Xu P, Zhao C.
    Mol Imaging Biol; 2016 Jun 18; 18(3):353-9. PubMed ID: 26452556
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of a New 99mTc-labeled GnRH Analogue as a Possible Imaging Agent for Prostate Cancer Detection.
    Farahani AM, Maleki F, Sadeghzadeh N, Abediankenari S, Abedi SM, Erfani M.
    Anticancer Agents Med Chem; 2020 Jun 18; 20(14):1695-1703. PubMed ID: 32560611
    [Abstract] [Full Text] [Related]

  • 13. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
    Qiu L, Tan H, Lin Q, Si Z, Mao W, Wang T, Fu Z, Cheng D, Shi H.
    Mol Imaging Biol; 2020 Aug 18; 22(4):842-853. PubMed ID: 31741201
    [Abstract] [Full Text] [Related]

  • 14. A novel molecular imaging probe [99mTc]Tc-HYNIC-FAPI targeting cancer-associated fibroblasts.
    Jiang Y, Tian Y, Feng B, Zhao T, Du L, Yu X, Zhao Q.
    Sci Rep; 2023 Mar 06; 13(1):3700. PubMed ID: 36879039
    [Abstract] [Full Text] [Related]

  • 15. Clinical translation of a PSMA inhibitor for 99mTc-based SPECT.
    Ferro-Flores G, Luna-Gutiérrez M, Ocampo-García B, Santos-Cuevas C, Azorín-Vega E, Jiménez-Mancilla N, Orocio-Rodríguez E, Davanzo J, García-Pérez FO.
    Nucl Med Biol; 2017 May 06; 48():36-44. PubMed ID: 28193503
    [Abstract] [Full Text] [Related]

  • 16. Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors.
    Larkina M, Varvashenya R, Yuldasheva F, Plotnikov E, Bezverkhniaia E, Tretyakova M, Zelchan R, Schulga A, Konovalova E, Vorobyeva A, Belousov M, Orlova A, Tolmachev V, Deyev S.
    Mol Pharm; 2024 Apr 01; 21(4):1919-1932. PubMed ID: 38557163
    [Abstract] [Full Text] [Related]

  • 17. A Novel Radioimmune 99mTc-Labeled Tracer for Imaging Sphingosine 1-Phosphate Receptor 1 in Tumor Xenografts: An In Vitro and In Vivo Study.
    Ye M, Gai Y, Ji H, Jiang Y, Qiao P, Wang W, Zhang Y, Xia X, Lan X.
    Front Immunol; 2021 Apr 01; 12():660842. PubMed ID: 34484174
    [Abstract] [Full Text] [Related]

  • 18. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z, Santos-Cuevas CL, Ocampo-García BE, Ferro-Flores G, García-Becerra R, Estrada G, Gómez-Argumosa E, Izquierdo-Sánchez V.
    Nucl Med Commun; 2014 Apr 01; 35(4):423-32. PubMed ID: 24335877
    [Abstract] [Full Text] [Related]

  • 19. 99mTc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging.
    Ahmadpour S, Noaparast Z, Abedi SM, Hosseinimehr SJ.
    J Biomed Sci; 2018 Feb 19; 25(1):17. PubMed ID: 29455647
    [Abstract] [Full Text] [Related]

  • 20. Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized α-MSH peptide in melanoma.
    Guo H, Miao Y.
    J Nucl Med; 2014 Dec 19; 55(12):2057-63. PubMed ID: 25453052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.